Xylazine, an important FDA approved prescription animal drug that is widely used in veterinary medicine, is getting the attention of regulators at the state and federal levels. Farm Bureau is monitoring the latest developments.
Xylazine, an important FDA approved prescription animal drug that is widely used in veterinary medicine, particularly in cattle for sedation for surgeries and procedures, is getting the attention of regulators at the state and federal levels.
While the Drug Enforcement Administration has indicated that there is no evidence to date that veterinary medicine has been a target to obtain xylazine for illegal purposes, it has been increasingly showing up in street drugs in combination with illicit fentanyl and other narcotics.
At the state level, Gov. Mike DeWine signed an executive order directing the State of Ohio Board of Pharmacy to immediately classify xylazine as a Schedule III controlled substance, making Ohio one of the first states in the nation to schedule xylazine as a controlled substance drug.
“While we understand the concerns of protecting our communities from the illicit use of all types of drugs, changing xylazine from a prescription to a controlled drug could impact veterinarians from an animal welfare standpoint and increase safety risks to those managing these animals,” said Roger High, director of livestock with Ohio Farm Bureau.
In recent months, Farm Bureau has been working alongside the Ohio Veterinary Medical Association and American Veterinary Medical Association to help the Food and Drug Administration and Congress find pathways to reduce the illicit use of xylazine while also ensuring accessibility in veterinary medicine.
“Central to the issue of controlled drug status for xylazine is not the additional record keeping and security measures involved, but rather the impact of such a move on accessibility of the drug in veterinary medicine,” according to a statement by OVMA. “Of the remaining two manufacturers of xylazine in North America, only one has DEA approval in its facility to manufacture Schedule III controlled drugs. The other has indicated that, if xylazine is made a controlled drug, they would not utilize their time, research and financial resources to achieve that status and would simply discontinue manufacturing it.”
OVMA says supply chain disruption is already a concern with xylazine and therefore the impact of losing another manufacturer would compound the problem significantly.
Bipartisan legislation, likely to be introduced in Congress in the next few weeks, would make xylazine a controlled drug for purposes of illicit use in humans, while keeping it a non-controlled drug for legitimate/licit use in nonhuman species. The change would give law enforcement added penalties for those found using xylazine in street drugs but keep pathways open for access and use in veterinary medicine.
Prior to the governor’s executive order, Ohio Farm Bureau, along with the Ohio Cattlemen’s Association and Ohio Dairy Producers Association made the DeWine administration aware of the above information, relative to maintaining the availability of xylazine in veterinary medicine and have encouraged them to wait for the national resolution, adding consistency across state lines.
Ohio’s livestock community and member organizations will remain actively engaged in working with Ohio regulators and national organization partners to help resolve this situation and will continue to keep members informed of new developments.
For more information regarding the emergency scheduling of xylazine visit the Ohio Department of Agriculture’s Xylazine FAQ page.
Ohio Farm Bureau recently published an op-ed in The Columbus Dispatch highlighting the importance of protecting private property rights as discussions continue around expanding eminent domain powers in Ohio.
Read More
Brad Bales, senior director of state and national policy for Ohio Farm Bureau, joins the podcast to discuss the importance of grassroots advocacy, the impact of sharing your story and why staying engaged matters.
Read More
Introduced by Rep. Sarah Fowler Arthur (R-Ashtabula) and Rep. David Thomas (R-Jefferson), the bill would add trees cultivated for maple syrup production to Ohio’s statutory definition of agriculture.
Read More
Ohio Farm Bureau shared members’ concerns about the rapid growth of data centers across the state and the long-term impacts on agriculture and rural communities.
Read More
Ohio Farm Bureau applauds the passage of H.R. 1346, allowing the year-round sale of E15, also known as Unleaded 88 fuel.
Read More
Congress is considering standalone legislation to allow the permanent, year-round sale of E15. Members can use the action center to contact their member of Congress.
Read More
Thanks to the engagement of Farm Bureau members, the U.S. House of Representatives passed a new farm bill April 30. American Farm Bureau President Zippy Duvall asked the Senate to quickly take the next step.
Read More
House Bill 125 will permit students to have a limited number of excused absences for 4-H and FFA events, ensuring they are not disciplined for attending.
Read More
County Farm Bureau leaders from all 88 Ohio counties are in the nation’s capital March 10-12, 2026 for the County Presidents’ Trip to Washington, D.C.
Read More
Senate Bill 328 is legislation designed to strengthen career-connected learning and better prepare students for Ohio’s workforce needs.
Read More
